Detalles de la búsqueda
1.
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Lancet
; 393(10168): 229-240, 2019 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30522922
2.
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 17(8): 1081-1093, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27345636
3.
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
Blood
; 115(18): 3664-70, 2010 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20197551
4.
Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
Blood
; 112(8): 3383-90, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650449
5.
Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
Bone Marrow Transplant
; 55(4): 840, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30862820
6.
Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant.
Transplantation
; 104(12): 2582-2590, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33104308
7.
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.
J Clin Oncol
; 37(8): 613-623, 2019 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30707661
8.
Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.
J Clin Oncol
; 36(22): 2259-2266, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29584548
9.
Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial.
Lancet Haematol
; 5(11): e543-e553, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30389036
10.
Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine.
Haematologica
; 90(1): ECR05, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15653459
11.
A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma.
Clin Cancer Res
; 21(13): 3013-9, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25779949
12.
Telomere shortening correlates with prognostic score at diagnosis and proceeds rapidly during progression of chronic myeloid leukemia.
Leuk Lymphoma
; 45(9): 1775-81, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15223635
13.
High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
Bone Marrow Transplant
; 54(3): 465-468, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30104718
14.
Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies.
Curr Hematol Malig Rep
; 6(4): 231-40, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21912848
15.
Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.
Front Oncol
; 1: 35, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22655241
16.
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia.
Blood
; 110(13): 4614-7, 2007 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17881635
17.
Late-appearing MLL rearrangement arising as a secondary change in adult acute myeloid leukemia.
Genes Chromosomes Cancer
; 34(1): 126-8, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-11921290
18.
Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission.
Br J Haematol
; 123(3): 479-83, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14617010
19.
Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.
Blood
; 99(6): 1928-37, 2002 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11877262
20.
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.
Br J Haematol
; 137(2): 170; author reply 171, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17391498